Drug profile

The FDA adverse-event record for Dhp Lv

34 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Dhp Lv. Species, reactions, and outcomes follow.

#1352 of 2,679
by report volume (all drugs)
34
adverse-event reports
14.7%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Dhp Lv ranks #1344 of 2679 by total reports (34). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1344
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Dhp Lv has 34 reports now versus 31 in that prior snapshot: 3 more (9.7%).

Report change
+3
Death-coded reports
+1
Death-coded share
+1.8 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Dhp Lv changes

Signature read: death-coded share at 14.7% is the most distinctive stamp on Dhp Lv's FDA AER row.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
34
Total Reports
5
Deaths Reported
14.7%
Death-coded share of reports

Active Ingredients

Dhp Lv

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 34

Most Affected Breeds

Crossbred Canine/dog 8
Retriever - Labrador 5
Terrier - Yorkshire 3
Shepherd Dog - Australian 3
Beagle 2
Coton de Tuléar 2
Boxer (German Boxer) 1
Chihuahua 1
Sheepdog - Old English 1
Bullmastiff 1

Most Reported Reactions

Vomiting 14
Emesis (multiple) 7
Fever 6
Other abnormal test result NOS 4
Lethargy (see also Central nervous system depression in 'Neurological') 4
Diarrhoea 4
Elevated alanine aminotransferase (ALT) 4
Neutrophilia 4
Death 4
Decreased appetite 3
Weight loss 3
Hyperglycaemia 3

Outcome Breakdown

Recovered/Normal
16 (47.1%)
Ongoing
11 (32.4%)
Died
4 (11.8%)
Outcome Unknown
2 (5.9%)
Euthanized
1 (2.9%)

Dhp Lv Adverse Event Insights

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Dhp Lv (#1352 of 2,679 by report volume); death-coded 14.7%. PlainBreed drug row · death-coded share stamp 14.7% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →